Biotropics Malaysia Berhad, a pioneer in developing bio-resources into scientifically proven natural products, has been serving local and international markets for nearly 20 years. Leveraging Malaysia's rich biodiversity and traditional knowledge, the company specializes in offering natural health solutions that are backed by evidence. Its award-winning portfolio includes Physta® Tongkat Ali Standardized Root Extract, BioKesum® Leaf Standardized Extract, SLP+® Kacip Fatimah (Labisia Pumila) Standardized Extract, Nu Femme® Extract (Tongkat Ali & Kacip Fatimah), EurectaTM (Tongkat Ali & Kesum Standardized Blends), and Activated Virgin Coconut Oil (AVCO®). These proprietary products cater to nutraceutical, functional food, and cosmeceutical applications, with a presence in over 35 countries.

Biotropics has filed over 70 global patents and conducted 57 internationally recognized scientific studies, many published in high-impact journals. Research has validated Tongkat Ali's traditional uses for male libido and highlighted its broader benefits, including testosterone enhancement, muscle building, fertility, immune support, stress management, glucose regulation, and women’s health. With the largest herbal extraction facility in Malaysia and the only one inspected under the US-FDA Establishment Inspection Report (EIR) program, Biotropics ensures its products meet the highest international standards.

Since 2007, Biotropics has established a strong global presence through appearances in trade journals, magazines, and TV programs in markets like the US and China. The company regularly participates in international trade events across Europe, Asia, and the Middle East, solidifying its reputation as a leading manufacturer of premium, science-backed, and patented herbal ingredients. Recognized as a success story by Malaysia’s Economic Planning Unit and the American Botanical Council, Biotropics continues to champion Malaysian herbs like Tongkat Ali and Kesum on the global stage.